Valuation — not yet established
No valuation for PrimeRx is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of PrimeRx with a free account
- ·Watch PrimeRx: the Monday email on marks, rounds and moves
PrimeRx funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2026 | Buyout/LBO (Add-on)† | — | ▮ | ▮ |
Unlock post-money valuations
Membership and data by Private Market View
How PrimeRx's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For PrimeRx, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about PrimeRx
- When did PrimeRx last raise?
- PrimeRx last raised in Feb 2026 (Buyout/LBO (Add-on)†).